⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Erasmus MC and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Erasmus MC
↗Rotterdam, Netherlands
Erasmus MC is the largest university medical center in the Netherlands, combining high-quality patient care with academic research and education. It operates as a major hub for medical innovation, particularly in oncology, transplantation, and rare diseases, and maintains a robust Technology Transfer Office (TTO) to bridge the gap between academic research and commercial healthcare applications.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Academic Medical Center / Translational Research
SIZE & FINANCIALS
Employees:10000+
Founded:1840
Ownership:government
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Preclinical/Early Clinical
Modalities:Gene therapy, Small molecule, Immunotherapy
Active Trials:100
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Erasmus MC Holding B.V.
Subsidiaries:Pepper Therapeutics B.V., LentiCure
Key Partnerships:Delft University of Technology (Convergence), Active Biotech, HOVON, BlinkLab
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Casper H.J. van Eijck - Professor and Pancreato-biliary Surgeon
LINKS
Website:erasmusmc.nl
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Erasmus MC. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.